Jerome Rouquet - Jun 12, 2023 Form 4 Insider Report for VISTEON CORP (VC)

Role: Senior Vice President & CFO
Signature: Heidi A. Sepanik, Secretary, Visteon Corporation on behalf of Jerome J Rouquet
Stock symbol: VC
Transactions as of: Jun 12, 2023
Transactions value $: -$1,265,312
Form type: 4
Date filed: 6/14/2023, 04:27 PM
Previous filing: Mar 17, 2023
Next filing: Feb 20, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VC	Common Stock	Sale	-$150K	-1K	-6.12%	$150.12	15.3K	Jun 12, 2023	Direct	F1, F2
transaction	VC	Common Stock	Sale	-$235K	-1.55K	-10.1%	$151.81	13.8K	Jun 13, 2023	Direct	F1, F3
transaction	VC	Common Stock	Sale	-$57K	-373	-2.71%	$152.69	13.4K	Jun 13, 2023	Direct	F1, F4
transaction	VC	Common Stock	Sale	-$16.5K	-109	-0.81%	$151.22	13.3K	Jun 13, 2023	Direct	F1, F5
transaction	VC	Common Stock	Sale	-$15.4K	-100	-0.75%	$153.64	13.2K	Jun 13, 2023	Direct	F1
transaction	VC	Common Stock	Options Exercise	$122K	+1.82K	+13.81%	$66.98	15K	Jun 12, 2023	Direct	F1
transaction	VC	Common Stock	Sale	-$274K	-1.82K	-12.13%	$150.23	13.2K	Jun 12, 2023	Direct	F1, F6
transaction	VC	Common Stock	Options Exercise	$504K	+7.53K	+57.01%	$66.98	20.7K	Jun 13, 2023	Direct	F1
transaction	VC	Common Stock	Sale	-$838K	-5.52K	-26.62%	$151.82	15.2K	Jun 13, 2023	Direct	F1, F7
transaction	VC	Common Stock	Sale	-$92.1K	-609	-4%	$151.22	14.6K	Jun 13, 2023	Direct	F1, F8
transaction	VC	Common Stock	Sale	-$214K	-1.4K	-9.59%	$152.82	13.2K	Jun 13, 2023	Direct	F1, F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VC	Employee stock option (right to buy)	Options Exercise	$0	-1.82K	-13%	$0.00	12.2K	Jun 12, 2023	Common Stock	1.82K	$66.98	Direct	F1, F10
transaction	VC	Employee stock option (right to buy)	Options Exercise	$0	-7.53K	-61.69%	$0.00	4.68K	Jun 13, 2023	Common Stock	7.53K	$66.98	Direct	F1, F10

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2023.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.00 - $150.59, inclusive. The reporting person undertakes to provide to Visteon Corporation, its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.39 - $152.37, inclusive.
F4	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.55 - $152.87, inclusive.
F5	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.38 - $151.30, inclusive.
F6	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.00 - $150.71, inclusive.
F7	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.39 - $152.35, inclusive.
F8	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.38 - $151.36, inclusive.
F9	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.39 - $153.34, inclusive.
F10	The option is exercisable to the extent of one third of the shares optioned after one year from the date of grant, two-thirds in two years and in full after three years.